U.S. markets closed
  • S&P 500

    -4.88 (-0.11%)
  • Dow 30

    +73.94 (+0.21%)
  • Nasdaq

    -125.50 (-0.82%)
  • Russell 2000

    -4.92 (-0.21%)
  • Crude Oil

    +1.48 (+1.79%)
  • Gold

    +11.20 (+0.63%)
  • Silver

    +0.22 (+0.91%)

    +0.0015 (+0.13%)
  • 10-Yr Bond

    -0.0210 (-1.25%)

    -0.0036 (-0.26%)

    -0.5080 (-0.45%)

    +489.77 (+0.80%)
  • CMC Crypto 200

    -49.69 (-3.31%)
  • FTSE 100

    +14.25 (+0.20%)
  • Nikkei 225

    +96.27 (+0.34%)

Cell Culture Consumables And Equipment Global Market Report 2021: COVID-19 Growth And Change To 2030

·5 min read

Major players in the cell culture consumables and equipment market are Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare and Merck KGaA. The global cell culture consumables and equipment market is expected to grow from $8.

New York, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Culture Consumables And Equipment Global Market Report 2021: COVID-19 Growth And Change To 2030" - https://www.reportlinker.com/p06151554/?utm_source=GNW
55 billion in 2020 to $9.46 billion in 2021 at a compound annual growth rate (CAGR) of 10.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $13.49 billion in 2025 at a CAGR of 9.3%.

The cell culture consumables and equipment global market consists of sales of cell culture consumables, equipment and related service.Cell culture consumables include sera, media, reagents, and equipment such as bioreactors, cell counters, filtration systems, centrifuges, and incubators.

The services includes only installation and maintenance services offered by equipment manufacturers. Cell culture consumables and equipment are designed to aid scientist in growing new cells in the culture media for drug development, tissue culture, and engineering, gene therapy, vaccine production and toxicity testing.

The cell culture consumables and equipment market covered in this report is segmented by product into consumables, instruments. It is also segmented by end user into industrial, biotechnology, agriculture, others; by application into vaccination, toxicity testing, cancer research, drug screening and development, recombinant products, stem cell technology, regenerative medicine, others; by consumables into media, sera, reagents and by instruments into cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, centrifuges.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contamination of cell culture is the most prominent factor restricting the growth of cell culture consumables and equipment market.Contaminated culture is the presence of non-living substances or unwanted foreign microorganisms that have undesirable effects on the cell culture.

Using contaminated culture cells has a number of negative consequences on the users and thus hampers the growth of this market.For example, an article published on MedCrave, stated that Mycloplasma is one of the most common and difficult to detect contaminants.

The article also highlighted the results of a study on fibroblasts and keratinocyte cell lines that showed 32.35% of contamination, out of which 17.65% were mycoplasma contaminated cultures, followed by fungal (8.82%) and bacterial (5.88%) contaminants. Hence, the high risk associated with cell culture techniques pose a threat to the growth of cell culture consumables and equipment market.

Companies in cell culture consumables and equipment are investing more in 3D cell culture for its new and advantageous features. 3D cell culture may be defined as the culture of living cells within micro-assembled devices and supports that present a three dimensional structure and are used to replicate a tissue or an organ in an artificial environment by allowing the cells to interact with the surroundings in all three directions. 3D cell cultures are more relevant with higher degree of structural complexity and maintains the steady state for more time as compared to 2D cell cultures. Visikol launched OpenLiver 3D cell culture models in January 2019 to enter into 3D cell culture technology.

Thermo Fisher acquired Brammer Bio for $1.7 billion in March 2019. Brammer Bio is a contract development and manufacturing organization (CDMO) for cell and gene treatment centered biotechs. This transaction will strengthen Thermo Fisher to grow faster and expand cell culture market in other countries. Brammer Bio is formed through the merger of Florida Biologix and Brammer Biopharmaceuticals in March 2016 and is headquartered in Cambridge, MA.

Increase in prevalence of chronic diseases is driving the growth of cell culture consumables and equipment market.Chronic diseases such as cancer, diabetes, heart diseases, obesity and hypertension are growing rapidly.

A few chronic diseases are caused due to loss or damage of certain type of cells.Such diseases can be cured by replacing the destroyed cells with new ones that are produced by pluripotent stem cells, using cell culture consumables and equipment.

So, with the rising incidence of chronic diseases, there is an increased need for such equipment that can produce new cells outside the natural environment, thus driving the growth for this market. For example, according to the World Health Organization, chronic disease prevalence is expected to rise by 57% by the year 2020.

FDA regulates the cell culture consumables and equipment in the U.S. Under title 21, Sec 864.2240. For cell and tissue culture equipment FDA states that if the equipment is not labelled or mentioned as sterile, they would be removed from good manufacturing practice of the quality system. Additionally, each manufacturing unit should maintain procedures to receive, review, and evaluate complaints. These procedures require consistency and punctuality along with the documentation of the receipts. Therefore, these regulatory standards improves the safety and efficacy of instruments and consumables used during cell culture processes.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Read the full report: https://www.reportlinker.com/p06151554/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001